Overview
LPCN market data
Price History
LPCN price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.77 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.36 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -571.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.81 – $12.37 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $17.6M · P/B 3.08 · P/S 8.77.
Company News
Lipocine Q2 EPS $(0.32) Beats $(0.43) Estimate, Sales $190.099K Beat $156.500K EstimateBenzinga · Aug 4, 2026, 10:19 AM
8-K filing — Lipocine Inc. (LPCN)SEC EDGAR · Aug 4, 2026, 10:08 AM
Lipocine To Announce Phase 3 Data For LPCN 1154 Treatment For Postpartum Depression On May 26Benzinga · May 19, 2026, 12:05 PM